Medical Care

Global Targeted Drug HER2 Inhibitors for NSCLC Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Targeted Drug HER2 Inhibitors for NSCLC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drug HER2 Inhibitors for NSCLC.
The Targeted Drug HER2 Inhibitors for NSCLC market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Drug HER2 Inhibitors for NSCLC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Drug HER2 Inhibitors for NSCLC companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer-Ingelheim
Roche
Mylan
Biocon
Segment by Type
Afatinib
Trastuzumab
Others
Segment by Application
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Drug HER2 Inhibitors for NSCLC company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Afatinib
1.2.3 Trastuzumab
1.2.4 Others
1.3 Market by Application
1.3.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Squamous Cell Carcinoma of NSCLC
1.3.3 Adenocarcinoma of NSCLC
1.3.4 Large Cell Carcinoma of NSCLC
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Perspective (2020-2031)
2.2 Global Targeted Drug HER2 Inhibitors for NSCLC Growth Trends by Region
2.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Region (2020-2025)
2.2.3 Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031)
2.3 Targeted Drug HER2 Inhibitors for NSCLC Market Dynamics
2.3.1 Targeted Drug HER2 Inhibitors for NSCLC Industry Trends
2.3.2 Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
2.3.3 Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
2.3.4 Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue
3.1.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue (2020-2025)
3.1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue
3.4 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio
3.4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2024
3.5 Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC Head office and Area Served
3.6 Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Product and Application
3.7 Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug HER2 Inhibitors for NSCLC Breakdown Data by Type
4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Type (2020-2025)
4.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031)
5 Targeted Drug HER2 Inhibitors for NSCLC Breakdown Data by Application
5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Application (2020-2025)
5.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2020-2031)
6.2 North America Targeted Drug HER2 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025)
6.4 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2020-2031)
7.2 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025)
7.4 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size (2020-2031)
8.2 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2020-2031)
9.2 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025)
9.4 Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size (2020-2031)
10.2 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer-Ingelheim
11.1.1 Boehringer-Ingelheim Company Details
11.1.2 Boehringer-Ingelheim Business Overview
11.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.1.4 Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
11.1.5 Boehringer-Ingelheim Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.2.4 Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.3.4 Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
11.3.5 Mylan Recent Development
11.4 Biocon
11.4.1 Biocon Company Details
11.4.2 Biocon Business Overview
11.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Introduction
11.4.4 Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
11.4.5 Biocon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Afatinib
Table 3. Key Players of Trastuzumab
Table 4. Key Players of Others
Table 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2020-2025)
Table 9. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2026-2031)
Table 11. Targeted Drug HER2 Inhibitors for NSCLC Market Trends
Table 12. Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
Table 13. Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
Table 14. Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players (2020-2025)
Table 17. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2024)
Table 18. Ranking of Global Top Targeted Drug HER2 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Headquarters and Area Served
Table 21. Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Product and Application
Table 22. Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2020-2025)
Table 26. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2026-2031)
Table 28. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2020-2025)
Table 30. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2026-2031)
Table 32. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 47. Boehringer-Ingelheim Company Details
Table 48. Boehringer-Ingelheim Business Overview
Table 49. Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product
Table 50. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 51. Boehringer-Ingelheim Recent Development
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche Targeted Drug HER2 Inhibitors for NSCLC Product
Table 55. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Mylan Company Details
Table 58. Mylan Business Overview
Table 59. Mylan Targeted Drug HER2 Inhibitors for NSCLC Product
Table 60. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 61. Mylan Recent Development
Table 62. Biocon Company Details
Table 63. Biocon Business Overview
Table 64. Biocon Targeted Drug HER2 Inhibitors for NSCLC Product
Table 65. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 66. Biocon Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report


List of Figures
Figure 1. Targeted Drug HER2 Inhibitors for NSCLC Picture
Figure 2. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type: 2024 VS 2031
Figure 4. Afatinib Features
Figure 5. Trastuzumab Features
Figure 6. Others Features
Figure 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2024 VS 2031
Figure 9. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 10. Adenocarcinoma of NSCLC Case Studies
Figure 11. Large Cell Carcinoma of NSCLC Case Studies
Figure 12. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered
Figure 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region: 2024 VS 2031
Figure 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players in 2024
Figure 17. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2024
Figure 19. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 21. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 25. Germany Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2020-2031)
Figure 33. China Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 41. Mexico Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 45. Turkey Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 50. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 51. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies